Clinical comparisons of RA between different populations: are they feasible?

Rheumatoid arthritis (RA) is the most common chronic inflammatory disease affecting about 1% of the white population, particularly female patients, and has considerable physical, psychological, and social repercussions.1 In a paper published previously in the Annals, Dadoniene et al described and co...

Descripción completa

Detalles Bibliográficos
Autores Principales: Cadena, J, Anaya, Juan-Manuel
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Annals of the Rheumatic Diseases 2003
Materias:
HLA
Acceso en línea:https://repository.urosario.edu.co/handle/10336/28426
http://dx.doi.org/10.1136/ard.62.11.1124
id ir-10336-28426
recordtype dspace
spelling ir-10336-284262021-08-11T04:00:48Z Clinical comparisons of RA between different populations: are they feasible? Comparaciones clínicas de AR entre diferentes poblaciones: ¿son factibles? Cadena, J Anaya, Juan-Manuel Rheumatoid arthritis (RA) Chronic inflammatory disease HLA Rheumatoid arthritis (RA) is the most common chronic inflammatory disease affecting about 1% of the white population, particularly female patients, and has considerable physical, psychological, and social repercussions.1 In a paper published previously in the Annals, Dadoniene et al described and compared two cohorts of patients with RA from Vilnius (Lithuania) and Oslo (Norway).2 There were no significant differences in sex, age, extra-articular manifestations, education, or family history of RA between the groups. None the less, there were important differences in disease activity, disability, pain, emotional, mental and general health, with patients in the Vilnius group having the worst scores. The number of patients who had never used a disease modifying antirheumatic drug (DMARD) was similar in both groups. Vilnius patients had more commonly used azathioprine, sulfasalazine, and antimalarial drugs, whereas Oslo patients had used methotrexate, gold salts, cyclosporin, and D-penicillamine. Surgery was more common in the Oslo patients. That study was developed to compare the evolution and outcomes of two different populations with RA and was the first to include health related quality of life. The authors attributed the differences between these groups to differences in economic status, medical care, drugs used and, to a lesser extent, genetic differences. 2003-10-28 2020-08-28T15:48:10Z info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion ISSN: 0003-4967 EISSN: 1468-2060 https://repository.urosario.edu.co/handle/10336/28426 http://dx.doi.org/10.1136/ard.62.11.1124 eng info:eu-repo/semantics/openAccess application/pdf Annals of the Rheumatic Diseases BMJ Publishing Annals of the Rheumatic Diseases
institution EdocUR - Universidad del Rosario
collection DSpace
language Inglés (English)
topic Rheumatoid arthritis (RA)
Chronic inflammatory disease
HLA
spellingShingle Rheumatoid arthritis (RA)
Chronic inflammatory disease
HLA
Cadena, J
Anaya, Juan-Manuel
Clinical comparisons of RA between different populations: are they feasible?
description Rheumatoid arthritis (RA) is the most common chronic inflammatory disease affecting about 1% of the white population, particularly female patients, and has considerable physical, psychological, and social repercussions.1 In a paper published previously in the Annals, Dadoniene et al described and compared two cohorts of patients with RA from Vilnius (Lithuania) and Oslo (Norway).2 There were no significant differences in sex, age, extra-articular manifestations, education, or family history of RA between the groups. None the less, there were important differences in disease activity, disability, pain, emotional, mental and general health, with patients in the Vilnius group having the worst scores. The number of patients who had never used a disease modifying antirheumatic drug (DMARD) was similar in both groups. Vilnius patients had more commonly used azathioprine, sulfasalazine, and antimalarial drugs, whereas Oslo patients had used methotrexate, gold salts, cyclosporin, and D-penicillamine. Surgery was more common in the Oslo patients. That study was developed to compare the evolution and outcomes of two different populations with RA and was the first to include health related quality of life. The authors attributed the differences between these groups to differences in economic status, medical care, drugs used and, to a lesser extent, genetic differences.
format Artículo (Article)
author Cadena, J
Anaya, Juan-Manuel
author_facet Cadena, J
Anaya, Juan-Manuel
author_sort Cadena, J
title Clinical comparisons of RA between different populations: are they feasible?
title_short Clinical comparisons of RA between different populations: are they feasible?
title_full Clinical comparisons of RA between different populations: are they feasible?
title_fullStr Clinical comparisons of RA between different populations: are they feasible?
title_full_unstemmed Clinical comparisons of RA between different populations: are they feasible?
title_sort clinical comparisons of ra between different populations: are they feasible?
publisher Annals of the Rheumatic Diseases
publishDate 2003
url https://repository.urosario.edu.co/handle/10336/28426
http://dx.doi.org/10.1136/ard.62.11.1124
_version_ 1712098369964343296
score 12,131701